← Eichor
Condition: Urinary Bladder Neoplasms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Urinary Bladder Neoplasms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer
Phase N/A · 1 location(s) · Lahey Clinic · NCT00872495Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT05126472Image-Guided Gynecologic Brachytherapy
NA · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT02993900Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer
NA · 8 location(s) · Tianjin Medical University Second Hospital · NCT07180212A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Phase N/A · 8 location(s) · Cedars-Sinai Medical Center · NCT03193541Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Phase N/A · 6 location(s) · University of Washington · NCT07225127Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2 · 3 location(s) · Tianjin Medical University Second Hospital · NCT07475403Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder
NA · 1 location(s) · Zhujiang Hospital · NCT03108196Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial
Phase N/A · 1 location(s) · OHSU Knight Cancer Institute · NCT07726602Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study
NA · 1 location(s) · University of Aarhus · NCT07339761Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Hist
Phase 2 · 4 location(s) · Emory University · NCT05756569Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Pa
Phase 2 · 16 location(s) · Theralase® Technologies Inc. · NCT03945162Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/Phase 2 · 1 location(s) · Dana-Farber Cancer Institute · NCT04724018Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Phase N/A · 1 location(s) · Origin Sciences · NCT05102110Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
Phase 2 · 1 location(s) · Mayo Clinic · NCT07087860Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)
Phase 3 · 3 location(s) · Rajiv Gandhi Cancer Institute & Research Center, India · NCT06712420Chemoablation for Low-Grade Bladder Cancer
Phase 2 · 1 location(s) · Ekaterina Laukhtina · NCT07019220The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
NA · 1 location(s) · RenJi Hospital · NCT06763354Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
NA · 2 location(s) · Johns Hopkins University · NCT05792722Liquid Biospy for Urinary Cancers
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06116396Measuring Surgical Recovery After Radical Cystectomy
Phase N/A · 11 location(s) · M.D. Anderson Cancer Center · NCT03193970Effects of Microbiological and Immunological Factors on the Lower Urinary Tract
Phase N/A · 1 location(s) · University of Zurich · NCT07494864Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients W
NA · 20 location(s) · Pacific Edge Limited · NCT06394869Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Phase 1/Phase 2 · 59 location(s) · Janssen Research & Development, LLC · NCT05316155Prophylactic Antibiotics in Cystectomy With Diversion
EARLY_Phase 1 · 1 location(s) · University of Minnesota · NCT06190197Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invas
Phase 3 · 11 location(s) · Astellas Pharma Global Development, Inc. · NCT07566156Outpatient Laser Ablation of Recurrent Non-muscle Invasive Bladder Cancer
Phase N/A · 1 location(s) · Jørgen Bjerggaard Jensen · NCT05337397A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unr
Phase 3 · 2 location(s) · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07424287Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06689176Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
NA · 2 location(s) · Johns Hopkins University · NCT07225205
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.